To develop a unani medicine for the treatment of subclinical hypothyroidism

A Clinical Study On Subclinical Hypothyroidism and its Management with An Extract of Jawarish e Bisbasa Formulation- A Randomized Double-Blind Placebo Controlled Clinical Trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034158

Enrollment

Registered

2021-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: 50% Hydro alcoholic Extract of jawarish e bisbasa formulation filled in 1 capsule (500mg) twice a day orally: 50% Hydro alcoholic Extract form of bisbasa(Myristica fragrans), zanzabeel(

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of subclinical hypothyroidism, patients willing to participate and sign the understood and informed consent form

Exclusion criteria

Exclusion criteria: Pregnant and lactating women, renal and hepatic sufficiency, malignancy, patient unwilling to sign the informed consent form, patient taking hormonal therapy

Design outcomes

Primary

Measure	Time frame
TSH, cold intolerance, tiredness, constipation will be assessedTimepoint: 6 weeks	—

Secondary

Measure	Time frame
To assess lipid profileTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Rais Ur Rahman

Ayurvedic and Unani Tibbia College Hospital

drrahman002@gmail.com9313980776

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026